• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

RFK Jr’s HHS to end routine COVID vaccine guidance for children, pregnant women: report

by May 16, 2025
written by May 16, 2025

The Trump administration is backing away from the Centers for Disease Control and Prevention (CDC) recommendations to vaccinate children and pregnant women against COVID-19, according to a new report.

The Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy, Jr., is planning to pull federal recommendations that these groups get the COVID vaccine as a routine measure, The Wall Street Journal reported Thursday.

The CDC currently recommends that everyone aged 6 months and older get vaccinated, but that guidance may be scrapped in the coming days.

It’s unclear whether HHS plans to drop the recommendation entirely or simply stop pushing it for everyone across the board, the report said.

The move would be a major shift in federal health policy and would mark a break from the blanket-vaccine approach that dominated the early years of the pandemic.

Few parents and expectant mothers have followed through with recent COVID boosters. As of April, CDC data shows just 13% of children and 14% of pregnant women had received the latest shot.

The change comes as the FDA, under Commissioner Dr. Marty Makary, prepares to roll out a tougher approval process for vaccines. 

Speaking Thursday at a gathering of food and drug lawyers, Makary said, ‘We want to see vaccines that are available for high-risk individuals, and at the same time, we want some good science. We want some good clinical data.’

Kennedy has long been critical of mRNA vaccines and mass vaccination campaigns. As HHS secretary, he now has the authority to revise CDC guidance. 

The Trump administration said it plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift in federal health policy, the WSJ reported.

The expected shift would undercut one of the most promoted health policies of the first Trump administration, Operation Warp Speed, and raise questions about whether insurers will continue covering the shots.

Critics of the move told the Journal it could discourage vaccination and leave immunocompromised people more vulnerable. Supporters say it brings policy back in line with science and common sense.

Both HHS and CDC did not immediately respond to Fox News Digital’s request for comment.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
State Department confirms ‘constructive’ nuclear talks with Iran; Trump says deal ‘sort of’ agreed to
next post
‘Shark Tank’ alum Bombas taps former Under Armour exec as CEO as it looks beyond digital roots

related articles

House Speaker Mike Johnson tells British Parliament he...

January 20, 2026

LIZ PEEK: Trump’s first year: The good, the...

January 20, 2026

Trump fires off late night Truth Social posts...

January 20, 2026

Denmark ramps up defenses in Greenland as Trump...

January 20, 2026

From Caracas to Chicago: Trump’s Article II powers...

January 19, 2026

Iran locks nation into ‘darker’ digital blackout, viewing...

January 19, 2026

Kaine vows new war powers fights after Senate...

January 19, 2026

Trump warns US can no longer think ‘purely...

January 19, 2026

Trump invites Putin, Lukashenko to join Gaza ‘Board...

January 19, 2026

Warren launches probe into major banks over Trump...

January 19, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Schumer coins ‘Trump shutdown,’ slamming GOP amid spending fight

    September 19, 2024
  • ‘Who wouldn’t want it?’: Netanyahu open to receiving stealth bombers, bunker-busters from US

    July 8, 2025
  • RNC chair reveals what role Trump will play during the 2026 midterms: ‘All the way to the finish line’

    December 14, 2024
  • JPMorgan upgrades Abercrombie & Fitch: Is the stock a buy with a $194 price target?

    July 22, 2024
  • YARDEN GONEN: Thank you, President Trump, for rescuing my sister from Hamas

    January 29, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,552)
  • Investing (848)
  • Stock (966)

Latest Posts

  • ‘New low’: Longtime House Dem ripped for ‘disgusting’ questioning of Musk’s loyalty to US as an immigrant

    February 27, 2025
  • Pentagon threatens no new limits on Ukraine weapons if North Korea joins Russia’s war

    October 30, 2024
  • GOP lawmakers advocate for US condemnation of persecution against Christians in Muslim-majority nations

    July 22, 2025

Recent Posts

  • Cannabis stocks surge as Trump signals shift on US marijuana policy

    December 13, 2025
  • Democratic AGs from 19 states sue Trump admin over DOGE access to sensitive, personal data at Treasury

    February 8, 2025
  • House GOP’s budget impasse thaws just as winter storm sacks Capitol

    February 13, 2025

Editor’s Pick

  • RFK Jr says Trump move is something no other president’s done before

    October 27, 2024
  • UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

    January 24, 2025
  • Biden pressing on with ‘full bore’ schedule, despite admission he needs to slow ‘pace’

    July 13, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock